See Egnyte's AI in action as it locates and classifies sensitive data across multiple content repositories and uses pre-built policies to achieve compliance.

Watch how to use Egnyte to share content and control access at a granular file and folder level, while providing users multiple ways to securely share content with external parties.

Implementing a New eQMS With Egnyte

In quality teams, a centralized and standardized process for managing quality control tasks is essential to driving efficiency across your organization. Join Sharon Reinhard, President of Clinical Compliance Solutions at Neuren Therapeutics, as she explores the multifaced journey of adopting Egnyte's Controlled Documents Module as an electronic Quality Management System (eQMS). She will highlight the challenges and successes encountered, showcasing how Neuren transformed their quality control process with Egnyte.

Global Drug Development: How Basis Digital Biotech Streamlines In-Licensing Processes With Egnyte

Many new biotech companies are formed by in-licensing therapies from the Asia-Pacific region, requiring the complex transfer and translation of thousands of clinical records. Listen to Jon Weiss, co-founder and chief innovation officer at Basis Bio, as he discusses how integrating Egnyte for Life Sciences with Smartsheet streamlines the process, ensuring accurate and efficient record management.

Beyond Big Pharma: Clinical Innovation for the Modern Biotech

With the proliferation of digital innovations, accessible data, and artificial intelligence, the time seems ripe for innovations to disrupt clinical trials. Despite these opportunities, trials today seem confounded by stalled recruitment, overwhelming volumes of data, and stretched resources. What are the greatest opportunities to remove these persistent barriers, and how can biotech agility outpace legacy pharma in adoption? From digitization to decentralization to automation and beyond, join Craig Lipset of Clinical Innovation Partners to explore how we modernize the clinical trial future patients deserve.

Subscribe to